Global Malaria Diagnostics Market Size, Share, Forecast Report, 2020-2027

The global malaria diagnostics market is expected to register a significant growth of 4.6 % CAGR during the forecast period (2018–2023)

Malaria is a serious life-threatening disease caused by a parasite, transmitted by the bite of infected anopheles mosquitoes. Infected mosquitoes transport the Plasmodium parasite. When the infected mosquito bites you, the parasite is released into your bloodstream. Once the human body becomes the host for the parasite it travels to the liver and matures. After some days, the mature parasite enters the bloodstream and starts to infect red blood cells (RBC). Humans suffering from malaria frequently experience fever, headache, weakness, vomiting

The improvements in technological advancements related to diagnostic tools with the growing demand for treatment in malaria-endemic countries is driving this market. Major factors driving the growth of the market are raising funds from the government, an increase in association between the industry and research centers. In the current years, there has been a renewed interest and commitment by the World Health Organization (WHO) to eradicate malaria in around 35 countries by 2030. World Health Organization (WHO) also estimated that by 2016, there would be 216 million clinical episodes and 445,000 deaths only due to malaria. The malaria diagnostic tests play a major role in recognizing the malarial cases and thus boosting the growth of malaria diagnosis market.

However, the dearth of appropriate monitoring standards at the country levels particularly in developing markets hinders the growth of the market. The weak regulatory framework and lack of awareness across the emerging nations is a prime concern for the manufacturers and healthcare providers. The absence of strong import export guidelines can lead to the use of substandard products that can lead to additional complications for patients. Besides, the long registration procedures, the market entry parameters must be assessed carefully for investment considerations.
Segmentation

The global malaria diagnostics market has been segmented on the basis of technology and end-user.

On the basis of technology, the market has been classified as rapid diagnostic tests, microscopy, and molecular diagnostic tests. The molecular diagnostics tests are segmented into polymerase chain reaction (PCR) and real-time polymerase chain reaction (RT-PCR).

On the basis of end-users, the market has been classified as hospitals, clinics, community healthcare, and others.
Key Players

Some of the key players in the global malaria diagnostics market are Access Bio. Inc., Abbott Laboratories, Premier Medical Corporation Pvt. Ltd, Sysmex Partec GmbH, bioMérieux, Beckman Coulter Inc., Siemens Healthineers, Leica Microsystems GmbH, Nikon Corporation, Olympus Corporation, and Bio-Rad Laboratories Inc.

Global Malaria Diagnostics Market, by Technique

• Rapid diagnostic tests
• Microscopy
• Molecular diagnostic tests
• Polymerase chain reaction (PCR)
• Real-time polymerase chain reaction (RT-PCR)

Global Malaria Diagnostics Market, by End-Users

• Hospitals
• Clinics
• Community healthcare
• Others

Global Malaria Diagnostics Market, by Region

Americas

• North America
• US
• Canada
• South America

Europe

• Western Europe
• Germany
• France
• Italy
• Spain
• UK
• Rest of Western Europe
• Eastern Europe

Asia-Pacific

• Japan
• China
• India
• Australia
• South Korea
• Rest of Asia-Pacific

Middle East & Africa

• Middle East
• Africa